Corinne Van Hoven, a senior honors medical diagnostics major, spent the summer conducting cancer research at Fox Chase Cancer ...

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, driven by marked molecular and clinical heterogeneity and ...

UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

Early detection of stomach cancer remains difficult, particularly in younger adults. The symptoms of this disease can be ...

When Gleevec was invented, or when it came out, that was a game-changer for patients with GIST, because they previously had ...

Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing at a CAGR of 6.4% during 2025–2035.

Olverembatinib shows promise in treating SDH-deficient GISTs, a rare tumor type with limited treatment options and high relapse risk. The phase 1b study demonstrated a 23.1% objective response rate ...

AstraZeneca’s Imfinzi is adding yet another landmark perioperative label to its belt with a new FDA approval that gives the drug the title of the first and only immunotherapy marketed to treat ...

Ascentage Pharma Group International Unsponsored ADR ( ($AAPG) ) has issued an update. On November 24, 2025, Ascentage Pharma announced the ...

Stomach cancer, once one of the deadliest cancers in the United States, has become less common over the past several decades. But public-health experts warn that the disease still poses a significant ...

DEAR MAYO CLINIC: My 39-year-old brother was just diagnosed with gastric cancer. The diagnosis was especially shocking because of his age. Is this becoming more common? Does age affect the approaches ...